Please use this identifier to cite or link to this item: doi:10.22028/D291-35108
Title: Control of TRPM3 Ion Channels by Protein Kinase CK2-Mediated Phosphorylation in Pancreatic β-Cells of the Line INS-1
Author(s): Becker, Alexander
Götz, Claudia
Montenarh, Mathias
Philipp, Stephan E.
Language: English
Title: International Journal of Molecular Sciences
Volume: 22
Issue: 23
Publisher/Platform: MDPI
Year of Publication: 2021
Free key words: transient receptor potential M 3 channels (TRPM3)
protein kinase CK2
calcium
glucosestimulated insulin release (GSIS)
INS-1
DDC notations: 610 Medicine and health
Publikation type: Journal Article
Abstract: In pancreatic β-cells of the line INS-1, glucose uptake and metabolism induce the openings of Ca2+-permeable TRPM3 channels that contribute to the elevation of the intracellular Ca2+ concen tration and the fusion of insulin granules with the plasma membrane. Conversely, glucose-induced Ca2+ signals and insulin release are reduced by the activity of the serine/threonine kinase CK2. There fore, we hypothesized that TRPM3 channels might be regulated by CK2 phosphorylation. We used recombinant TRPM3α2 proteins, native TRPM3 proteins from INS-1 β-cells, and TRPM3-derived oligopeptides to analyze and localize CK2-dependent phosphorylation of TRPM3 channels. The func tional consequences of CK2 phosphorylation upon TRPM3-mediated Ca2+ entry were investigated in Fura-2 Ca2+-imaging experiments. Recombinant TRPM3α2 channels expressed in HEK293 cells displayed enhanced Ca2+ entry in the presence of the CK2 inhibitor CX-4945 and their activity was strongly reduced after CK2 overexpression. TRPM3α2 channels were phosphorylated by CK2 in vitro at serine residue 1172. Accordingly, a TRPM3α2 S1172A mutant displayed enhanced Ca2+ entry. The TRPM3-mediated Ca2+ entry in INS-1 β-cells was also strongly increased in the presence of CX-4945 and reduced after overexpression of CK2. Our study shows that CK2-mediated phosphorylation controls TRPM3 channel activity in INS-1 β-cells.
DOI of the first publication: 10.3390/ijms222313133
Link to this record: urn:nbn:de:bsz:291--ds-351083
hdl:20.500.11880/32142
http://dx.doi.org/10.22028/D291-35108
ISSN: 1422-0067
Date of registration: 6-Jan-2022
Faculty: M - Medizinische Fakultät
Department: M - Experimentelle und Klinische Pharmakologie und Toxikologie
M - Medizinische Biochemie und Molekularbiologie
Professorship: M - Prof. Dr. Robert Ernst
M - Keiner Professur zugeordnet
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
File Description SizeFormat 
ijms-22-13133-v3.pdf2,7 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons